Antifungal compounds and methods of forming the same

US11851391B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11851391-B2
Application numberUS-201916514276-A
CountryUS
Kind codeB2
Filing dateJul 17, 2019
Priority dateJul 17, 2018
Publication dateDec 26, 2023
Grant dateDec 26, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An antifungal composition and a method of treating a systemic fungal infection are provided herein. The antifungal composition includes a diaryl bishydrazone. The method includes administering a therapeutically effective amount of the diaryl bishydrazone to a subject in need thereof.

First claim

Opening claim text (preview).

What is claimed is: 1. An antifungal composition comprising a compound according to Formula (I): or a pharmaceutically acceptable salt thereof; wherein each R is independently selected from the group consisting of H and a lower alkyl; and wherein each X is independently selected from the group consisting of phenyl, a substituted phenyl, an aromatic heterocycle, and a substituted aromatic heterocycle, so long as when both R are H or methyl then at least one X is not phenyl or meta-methoxy substituted phenyl; wherein the substituted phenyl comprises a substitution selected from the group consisting of nitro, an alkyl, an alkoxy, a halogen, cyano, a carboxylic acid, a sulfonic acid, aryl sulfoxides, aryl sulfones, a trihalomethyl, and combinations thereof; and aromatic heterocycle or the substituted aromatic heterocycle comprises one or more heteroatoms selected from the group consisting nitrogen, oxygen, sulfur, and combinations thereof, wherein the aryl sulfoxides include S(═O)C 6 H 4 Z, with Z being selected from the group consisting of alkyl, alkoxy, and halogen. 2. An antifungal composition comprising a compound according to Formula (I): or a pharmaceutically acceptable salt thereof; wherein each R is independently selected from the group consisting of H and a lower alkyl; and wherein each X is independently selected from the group consisting of phenyl, a substituted phenyl, an aromatic heterocycle, and a substituted aromatic heterocycle, so long as when both R are H or methyl then at least one X is not phenyl or meta-methoxy substituted phenyl; wherein the substituted phenyl comprises a substitution selected from the group consisting of nitro, an alkyl, an alkoxy, a halogen, cyano, a carboxylic acid, a sulfonic acid, aryl sulfoxides, aryl sulfones, a trihalomethyl, and combinations thereof; and aromatic heterocycle or the substituted aromatic heterocycle comprises one or more heteroatoms selected from the group consisting nitrogen, oxygen, sulfur, and combinations thereof, wherein the aryl sulfones include S(═O) 2 C 6 H 4 Z, with Z being selected from the group consisting of alkyl, alkoxy, and halogen. 3. An antifungal composition comprising a compound according to Formula (I): or a pharmaceutically acceptable salt thereof; wherein each R is independently selected from the group consisting of H and a lower alkyl; and wherein each X is independently selected from the group consisting of phenyl, a substituted phenyl, an aromatic heterocycle, and a substituted aromatic heterocycle, so long as when both R are H or methyl then at least one X is not phenyl or meta-methoxy substituted phenyl; wherein the substituted phenyl comprises a substitution selected from the group consisting of nitro, an alkyl, an alkoxy, a halogen, cyano, a carboxylic acid, a sulfonic acid, aryl sulfoxides, aryl sulfones, a trihalomethyl, and combinations thereof; and aromatic heterocycle or the substituted aromatic heterocycle comprises one or more heteroatoms selected from the group consisting nitrogen, oxygen, sulfur, and combinations thereof, wherein the substituent of the first ring according to Formula I is in the 3 position. 4. An antifungal composition comprising a compound according to Formula (I): or a pharmaceutically acceptable salt thereof; wherein each R is independently selected from the group consisting of H and a lower alkyl; and wherein each X is independently selected from the group consisting of phenyl, a substituted phenyl, an aromatic heterocycle, and a substituted aromatic heterocycle, so long as when both R are H or methyl then at least one X is not phenyl or meta-methoxy substituted phenyl; wherein the substituted phenyl comprises a substitution selected from the group consisting of nitro, an alkyl, an alkoxy, a halogen, cyano, a carboxylic acid, a sulfonic acid, aryl sulfoxides, aryl sulfones, a trihalomethyl, and combinations thereof; and aromatic heterocycle or the substituted aromatic heterocycle comprises one or more heteroatoms selected from the group consisting nitrogen, oxygen, sulfur, and combinations thereof, wherein the substituent of the first ring according to Formula I is in the 4 position. 5. The composition of claim 4 , wherein the R in the substituent of the first ring is methyl. 6. An antifungal composition comprising a compound according to Formula (I): or a pharmaceutically acceptable salt thereof; wherein each R is independently selected from the group consisting of H and a lower alkyl; wherein X is a substituted phenyl and the substituted phenyl comprises a substitution selected from the group consisting of nitro, an alkyl, an alkoxy, a halogen, cyano, a carboxylic acid, a sulfonic acid, aryl sulfoxides, aryl sulfones, a trihalomethyl, and combinations thereof, wherein the substituted phenyl includes more than one substitution. 7. The composition of claim 6 , wherein the substituted phenyl is disubstituted. 8. The composition of claim 7 , wherein the disubstituted phenyl is halogen substituted.

Assignees

Inventors

Classifications

  • C07C243/10Primary

    Hydrazines · CPC title

  • A61P31/10Primary

    Antimycotics · CPC title

  • Preparation of guanidine or its derivatives, i.e. compounds containing the group [IMAGE cpc-sch-C07C-0970.gif], the singly-bound nitrogen atoms not being part of nitro or nitroso groups · CPC title

  • having doubly-bound carbon atoms of hydrazone groups bound to carbon atoms of six-membered aromatic rings · CPC title

  • the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11851391B2 cover?
An antifungal composition and a method of treating a systemic fungal infection are provided herein. The antifungal composition includes a diaryl bishydrazone. The method includes administering a therapeutically effective amount of the diaryl bishydrazone to a subject in need thereof.
Who is the assignee on this patent?
Univ Kentucky Res Found
What technology area does this patent fall under?
Primary CPC classification C07C243/10. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 7 related publications on this page (citations in our corpus or others sharing the same primary CPC).